
Lisa V. Cook
Examiner (ID: 13949, Phone: (571)272-0816 , Office: P/1678 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1641, 1642, 1678, 1677 |
| Total Applications | 1370 |
| Issued Applications | 805 |
| Pending Applications | 161 |
| Abandoned Applications | 418 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18323939
[patent_doc_number] => 20230122067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => REAGENT COMPRISING ANTIBODY FROM WHICH PART OF Fc REGION IS DELETED
[patent_app_type] => utility
[patent_app_number] => 17/914282
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914282 | REAGENT COMPRISING ANTIBODY FROM WHICH PART OF Fc REGION IS DELETED | Mar 24, 2021 | Pending |
Array
(
[id] => 18265476
[patent_doc_number] => 20230086718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER
[patent_app_type] => utility
[patent_app_number] => 17/906273
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906273 | METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER | Mar 18, 2021 | Abandoned |
Array
(
[id] => 16949453
[patent_doc_number] => 20210208144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => MITOCHONDRIAL PROTEASE OMA1 AS A MARKER FOR BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/188006
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188006 | MITOCHONDRIAL PROTEASE OMA1 AS A MARKER FOR BREAST CANCER | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16993248
[patent_doc_number] => 20210231668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY
[patent_app_type] => utility
[patent_app_number] => 17/169033
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169033 | KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY | Feb 4, 2021 | Abandoned |
Array
(
[id] => 19275498
[patent_doc_number] => 12025621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
[patent_app_type] => utility
[patent_app_number] => 17/161783
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 76
[patent_no_of_words] => 42295
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/161783 | Atypical hemolytic uremic syndrome (AHUS) biomarker proteins | Jan 28, 2021 | Issued |
Array
(
[id] => 18421605
[patent_doc_number] => 20230176069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MITIGATING CONCENTRATION EFFECTS OF ANTIBODY DIGESTION FOR COMPLETE SEQUENCE COVERAGE
[patent_app_type] => utility
[patent_app_number] => 17/796203
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796203 | MITIGATING CONCENTRATION EFFECTS OF ANTIBODY DIGESTION FOR COMPLETE SEQUENCE COVERAGE | Jan 27, 2021 | Pending |
Array
(
[id] => 18178460
[patent_doc_number] => 20230039189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => POPULATION OF ANTIBODIES COMPRISING HOMOGENEOUS ANTIBODIES EACH HAVING LEFT-RIGHT ASYMMETRIC SUGAR CHAINS, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/758469
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758469 | POPULATION OF ANTIBODIES COMPRISING HOMOGENEOUS ANTIBODIES EACH HAVING LEFT-RIGHT ASYMMETRIC SUGAR CHAINS, AND METHOD FOR PRODUCING SAME | Dec 27, 2020 | Pending |
Array
(
[id] => 18243000
[patent_doc_number] => 20230075311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => PROGNOSTIC BIOMARKER OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/788632
[patent_app_country] => US
[patent_app_date] => 2020-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788632 | PROGNOSTIC BIOMARKER OF CANCER | Dec 24, 2020 | Pending |
Array
(
[id] => 18484903
[patent_doc_number] => 20230212217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Method for Purifying Biologically Active Peptide by Using Protein A Affinity Chromatography
[patent_app_type] => utility
[patent_app_number] => 17/789163
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789163 | Method for Purifying Biologically Active Peptide by Using Protein A Affinity Chromatography | Dec 23, 2020 | Pending |
Array
(
[id] => 16992299
[patent_doc_number] => 20210230719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/133870
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133870
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133870 | COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME | Dec 23, 2020 | Pending |
Array
(
[id] => 16807910
[patent_doc_number] => 20210130463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY
[patent_app_type] => utility
[patent_app_number] => 17/131326
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131326 | Checkpoint blockade and microsatellite instability | Dec 21, 2020 | Issued |
Array
(
[id] => 17587719
[patent_doc_number] => 11325975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Checkpoint blockade and microsatellite instability
[patent_app_type] => utility
[patent_app_number] => 17/131339
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 11325
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131339 | Checkpoint blockade and microsatellite instability | Dec 21, 2020 | Issued |
Array
(
[id] => 17620181
[patent_doc_number] => 11339219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Checkpoint blockade and microsatellite instability
[patent_app_type] => utility
[patent_app_number] => 17/131328
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 11520
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131328 | Checkpoint blockade and microsatellite instability | Dec 21, 2020 | Issued |
Array
(
[id] => 18582953
[patent_doc_number] => 20230265212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION
[patent_app_type] => utility
[patent_app_number] => 17/787773
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787773 | COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION | Dec 20, 2020 | Pending |
Array
(
[id] => 18989012
[patent_doc_number] => 20240060981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => OVARIAN CANCER BIOMARKER DETECTION THROUGH OVARIAN BLOOD SAMPLING
[patent_app_type] => utility
[patent_app_number] => 17/787868
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787868 | Ovarian cancer biomarker detection through ovarian blood sampling | Dec 17, 2020 | Issued |
Array
(
[id] => 19227757
[patent_doc_number] => 12007391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
[patent_app_type] => utility
[patent_app_number] => 17/101693
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 10286
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101693
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101693 | Means and methods for determining risk of type-1 diabetes by serum protein biomarkers | Nov 22, 2020 | Issued |
Array
(
[id] => 17096917
[patent_doc_number] => 20210284708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1
[patent_app_type] => utility
[patent_app_number] => 17/090566
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090566 | METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1 | Nov 4, 2020 | Abandoned |
Array
(
[id] => 16848185
[patent_doc_number] => 20210148930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Methods of Detecting and Preventing Atopic Allergic Diseases
[patent_app_type] => utility
[patent_app_number] => 17/078417
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17078417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/078417 | Methods of Detecting and Preventing Atopic Allergic Diseases | Oct 22, 2020 | Pending |
Array
(
[id] => 18903955
[patent_doc_number] => 20240019440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => MULTIPLE ANALYTE FECAL ANTIGEN TESTING
[patent_app_type] => utility
[patent_app_number] => 17/769533
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769533 | MULTIPLE ANALYTE FECAL ANTIGEN TESTING | Oct 15, 2020 | Pending |
Array
(
[id] => 16673161
[patent_doc_number] => 20210061924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => NOVEL ANTI-THYMIDINE KINASE ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/069349
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/069349 | Anti-thymidine kinase antibodies | Oct 12, 2020 | Issued |